Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
基本信息
- 批准号:7514173
- 负责人:
- 金额:$ 15.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-15 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAlcohol abuseAlcohol consumptionAmericanAndrogen ReceptorAndrogensAwardBinding ProteinsBiologicalBiopsy SpecimenBloodCAG repeatCase-Control StudiesCentral obesityChronicCirrhosisCollectionDNADataDepositionDevelopmentDiabetes MellitusDigestive System DisordersElevationEnrollmentEnvironmentEnvironmental ExposureEnvironmental Risk FactorEpidemicEpidemiologic MethodsEvaluationExposure toFatty LiverFatty acid glycerol estersFibrosisFoundationsFutureGastroenterologyGenderGene ExpressionGenesGeneticGenetic PolymorphismGenetic VariationGenotypeGoalsGonadal Steroid HormonesHealthHepatitis BHepatitis CHepatitis C virusHormone ReceptorHydroxysteroid DehydrogenasesIndividualInfectionInflammationInjuryInsulin ResistanceInsulin Resistance PathwayJointsLeptinLeukocytesLinkLiverLiver FibrosisLiver diseasesMeasuresMediatingMedical centerMentorsMessenger RNAMetabolic PathwayMethodsMolecular EpidemiologyMolecular GeneticsNecrosisNewly DiagnosedNumbersObesityOutcomePathogenesisPathologistPathway interactionsPatientsPeripheralPeroxisome Proliferator-Activated ReceptorsPlayPolycystic Ovary SyndromePredispositionPrimary Health CarePrimary carcinoma of the liver cellsPrincipal InvestigatorRNAReceptor GeneRegulatory ElementRelative RisksResearchResearch PersonnelRiskRisk FactorsRoleSamplingScoreSerologicalSeveritiesSpecimenStandards of Weights and MeasuresSteatohepatitisSterolsSusceptibility GeneTestingTestosteroneTexasTrainingVariantVeteransWomanWorkabdominal fatadiponectinbasecohortendophenotypegene environment interactiongene interactiongenetic associationgenetic epidemiologyliver biopsymalemembermenmicrosomal triglyceride transfer proteinnoveloncologyperipheral bloodprogramsprospectivereceptorresponseskills
项目摘要
DESCRIPTION (provided by applicant):
An estimated 20-30% of the four million Americans with hepatitis C infection (HCV) are projected to develop advanced fibrosis and cirrhosis after 2-3 decades of infection. Differences in exposure to fibrosis-promoting risk factors like alcohol abuse likely explain some of this difference in fibrosis risk. However, current research suggests that genetic factors may also influence the risk of advanced fibrosis in HCV patients. Two factors that research has repeatedly shown to be associated with development of advanced liver disease are male gender and abdominal obesity. However, the specific role genetic factors, including those related to male sex hormone receptor or androgen receptors (AR) and to insulin resistance (IR) associated with abdominal obesity, may play in fibrosis risk remains unclear. The goal of the proposed study is to ascertain the role that changes in AR and IR genes play in increasing risk of advanced fibrosis. The associated specific aims are: 1) to identify and collect data on a large and representative cohort of male veterans with HCV infection; 2) to test the hypothesis that 'high risk" variants of genes related to IR either alone or in conjunction with abdominal obesity increase fibrosis risk; and 3) to test the hypothesis that 'high risk' variants of genes related to AR also increase fibrosis risk. Aim 1 will be accomplished with standard epidemiology methods for cohort identification and will be performed at the Michael E. DeBakey VA. Aims 2 and 3 will be addressed through a case-control study in which cohort members with advanced fibrosis (cases) are compared to those with mild fibrosis (controls). The research plan, didactic training and outstanding mentoring environment will work together to allow the principal investigator to acquire new skills as well as refine existing skills in the development and execution of novel genetic epidemiology studies, allowing her to develop into an independent investigator in genetic epidemiology of chronic liver and digestive disorders.
描述(由申请人提供):
在感染了2 - 3年后,估计有400万美国人患有丙型肝炎感染(HCV)的美国人中有20-30%被预计将发展晚期纤维化和肝硬化。促进纤维化风险因素(如酗酒)的暴露差异可能解释了纤维化风险的某些差异。但是,当前的研究表明,遗传因素也可能影响HCV患者晚期纤维化的风险。研究反复证明与晚期肝病发展有关的两个因素是男性性别和腹部肥胖。但是,包括与男性性激素受体或雄激素受体(AR)有关的特定作用遗传因素以及与腹部肥胖相关的胰岛素抵抗(IR)的特定作用可能尚不清楚。拟议的研究的目的是确定AR和IR基因在增加晚期纤维化风险中的变化的作用。相关的特定目的是:1)识别和收集有关HCV感染的大型男性退伍军人队列的数据; 2)检验以下假设:“高风险”与IR单独或与腹部肥胖相关的基因的变异变异增加了纤维化的风险; 3)检验以下假说,即与AR相关的基因的“高风险”变异也会增加纤维化的风险。AIM 1将与COREDECHERID and CORDECHESS一起识别,并将其用于迈克尔的目标。通过一项病例对照研究,将具有晚期纤维化(病例)的队列成员与有轻度纤维化的组件进行比较(对照)。疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donna Lorraine White其他文献
Donna Lorraine White的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donna Lorraine White', 18)}}的其他基金
Sex hormones and HCV-related liver disease progression
性激素和 HCV 相关肝病进展
- 批准号:
9979785 - 财政年份:2017
- 资助金额:
$ 15.79万 - 项目类别:
Androgen Receptor Pathway and Risk of Hepatic Fibrosis in Hepatitis C
丙型肝炎中雄激素受体途径和肝纤维化风险
- 批准号:
8446061 - 财政年份:2013
- 资助金额:
$ 15.79万 - 项目类别:
Androgen Receptor Pathway and Risk of Hepatic Fibrosis in Hepatitis C
丙型肝炎中雄激素受体途径和肝纤维化风险
- 批准号:
8653960 - 财政年份:2013
- 资助金额:
$ 15.79万 - 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
- 批准号:
7928376 - 财政年份:2008
- 资助金额:
$ 15.79万 - 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
- 批准号:
8128652 - 财政年份:2008
- 资助金额:
$ 15.79万 - 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
- 批准号:
7686059 - 财政年份:2008
- 资助金额:
$ 15.79万 - 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
- 批准号:
8319548 - 财政年份:2008
- 资助金额:
$ 15.79万 - 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
- 批准号:
7918135 - 财政年份:2008
- 资助金额:
$ 15.79万 - 项目类别:
相似国自然基金
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:32100463
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
发展高级固体核磁方法探索功能材料的表界面化学
- 批准号:21922410
- 批准年份:2019
- 资助金额:120 万元
- 项目类别:优秀青年科学基金项目
TACSTD2在卵巢高级别浆液性癌发生发展中的作用及分子机制研究
- 批准号:81402157
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of non-canonical opioid signaling in the prefrontal cortex of alcohol-dependent rats
酒精依赖大鼠前额叶皮层非典型阿片类药物信号传导的研究
- 批准号:
10811444 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
An enzyme-based assay for the detection of acetaldehyde-protein adducts
用于检测乙醛-蛋白质加合物的酶测定法
- 批准号:
10760201 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Promoting Rapid Uptake of Multilevel Latent Class Modeling via Best Practices: Investigating Heterogeneity in Daily Substance Use Patterns
通过最佳实践促进多级潜在类建模的快速采用:调查日常物质使用模式的异质性
- 批准号:
10739994 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Racialized Sexual Discrimination (RSD) and Psychological Well-being among Young Sexual Minority Men of Color (YSMMoC)
年轻性少数有色人种男性中的种族化性别歧视 (RSD) 和心理健康 (YSMMoC)
- 批准号:
10353218 - 财政年份:2022
- 资助金额:
$ 15.79万 - 项目类别:
Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
测试招募性少数癌症患者进行癌症研究的有效方法
- 批准号:
10515913 - 财政年份:2022
- 资助金额:
$ 15.79万 - 项目类别: